Sign In

Amyn Sayani

Pharmaceuticals/Biotech leader: Pharma R&D, medical affairs and evidence generation

Amyn Sayani is a pharmaceutical industry professional with extensive experience in drug development and medical evidence. He currently holds the position of Director, Medical Evidence at AstraZeneca Canada.4

Professional Background

Amyn Sayani has over 20 years of experience in the pharmaceutical industry, covering various aspects of drug development.1 His expertise includes:

  • Pre-clinical and pre-formulation development
  • Formulation development
  • Real-world evidence
  • Outcomes research

Current Role

As the Director of Medical Evidence at AstraZeneca Canada, Amyn Sayani is responsible for:

  • Overseeing real-world evidence initiatives
  • Managing outcomes research projects
  • Contributing to the company's medical evidence strategy

Additional Involvement

Beyond his primary role at AstraZeneca, Amyn Sayani is also involved in:

  • The Canadian Society for Pharmaceutical Sciences, where he serves on the Board of Directors4
  • Supporting AstraZeneca's investments in life sciences in Ontario and Canada2

Amyn Sayani's LinkedIn profile reflects his professional experience and current position at AstraZeneca, aligning with the username "amynsayani" mentioned in the query.13

Highlights

Mar 12 · cspscanada.org
Amyn Sayani - Canadian Society for Pharmaceutical Sciences

Related Questions

What are Amyn Sayani's key achievements at AstraZeneca?
How has Amyn Sayani contributed to drug development in his career?
What specific projects has Amyn Sayani led at AstraZeneca?
What is Amyn Sayani's educational background?
How does Amyn Sayani's role at AstraZeneca impact the company's drug development process?
Amyn Sayani
Amyn Sayani, photo 1
Amyn Sayani, photo 2
Add to my network

Location

Toronto, Ontario, Canada